Vokes EE - Search Results

1

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.

Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Haraf DJ, Hellman S, Weichselbaum RR. Salama JK, et al. Among authors: vokes ee. Clin Cancer Res. 2008 Aug 15;14(16):5255-9. doi: 10.1158/1078-0432.CCR-08-0358. Clin Cancer Res. 2008. PMID: 18698045 Clinical Trial.

2

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1992 Sep 1;52(17):4832-6. Cancer Res. 1992. PMID: 1324797

3

Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience.

Gradishar W, Vokes E, Schilsky R, Weichselbaum R, Panje W. Gradishar W, et al. Med Pediatr Oncol. 1991;19(1):8-15. doi: 10.1002/mpo.2950190103. Med Pediatr Oncol. 1991. PMID: 1990260

4

Surgical management of the head and neck cancer patient following concomitant multimodality therapy.

Panje WR, Namon AJ, Vokes E, Haraf DJ, Weichselbaum RR. Panje WR, et al. Laryngoscope. 1995 Jan;105(1):97-101. doi: 10.1288/00005537-199501000-00021. Laryngoscope. 1995. PMID: 7837923

5

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1993 Aug 15;53(16):3667-9. Cancer Res. 1993. PMID: 8339273

6

The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.

List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. List MA, et al. Cancer. 1996 Jun 1;77(11):2294-301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. Cancer. 1996. PMID: 8635098

7

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E. List MA, et al. Qual Life Res. 1997 Apr;6(3):274-84. doi: 10.1023/a:1026419023481. Qual Life Res. 1997. PMID: 9226985

8

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.

List MA, Lee Rutherford J, Stracks J, Haraf D, Kies MS, Vokes EE. List MA, et al. Among authors: vokes ee. Cancer. 2002 Jul 1;95(1):98-104. doi: 10.1002/cncr.10653. Cancer. 2002. PMID: 12115322 Free article.

9

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.

Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Hoffman PC, et al. Among authors: vokes ee. Lung Cancer. 2002 Oct;38(1):65-71. doi: 10.1016/s0169-5002(02)00144-7. Lung Cancer. 2002. PMID: 12367795 Clinical Trial.

10

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ. Vokes EE, et al. J Clin Oncol. 2003 Jan 15;21(2):320-6. doi: 10.1200/JCO.2003.06.006. J Clin Oncol. 2003. PMID: 12525525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page